Audio Interview

Towards developing a universal influenza vaccine

Published on April 1, 2018   23 min

Other Talks in the Playlist: Research and Clinical Interviews

Please wait while the transcript is being prepared...
Interviewer: Professor Palese, thank you for sparing the time today. I very much enjoyed your talk in the collection on influenza. The subject today is Universal Influenza Vaccines. As I understand it, as one of your research projects, you are committed to attempting to develop a universal influenza vaccine. Is that right? Prof. Palese: Correct. Absolutely. So, my name is Peter Palese. I'm Professor and Chair of Microbiology at the Icahn School of Medicine at Mount Sinai, this is in Manhattan, New York, and we are working on the development of new and improved influenza virus vaccines. As you are probably aware of, influenza virus vaccines have to be administered every year, and the reason is that the virus, the influenza viruses, change, and every year we have to deal with new slightly different variants, and therefore, we have to administer influenza virus vaccines on an annual basis. To avoid that and to make vaccines which would last 20 years or a lifetime, we and others are trying to develop universal influenza virus vaccines. Interviewer: You're seeking to do this in humans. Is there any merit in expanding the concept to animal hosts from which recombinant viruses may emanate? Prof. Palese: Okay. So this was a very or is a very complex question you are asking.

Towards developing a universal influenza vaccine

Embed in course/own notes